Impaired glucose tolerance in pregnant women with polycystic ovary syndrome

Obstetrics and Gynecology

Volumn 94, Issue 2, 1999, Pages 194-197

  Radon, Paula A ^a   McMahon, Michael J ^a   Meyer, William R ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; FOLLITROPIN; GLUCOSE; LUTEINIZING HORMONE;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; DIABETES MELLITUS; DIABETES, GESTATIONAL; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0032791253     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(99)00252-5     Document Type: Article

References (19)

1. Dunaif A. Insulin resistance and the polycystic ovary syndrome Mechanisms and implications for pathogenesis . Endocr Rev. 18:1997;774-800.
2. Nestler J.E., Jakubowicz D.J. Decreases in ovarian cytochrome P4450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med. 335:1996;617-623.
3. Ehrmann D.A., Schneider D.J., Sobel B.E., Cavaghn M.K., Imperial J., Rosenfeld R.L., et al. Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 82:1997;2108-2116.
4. Wild R.A. Obesity, lipids, cardiovascular risk, and androgen excess. Am J Med. 98:1995;27S-32S.
5. Knopp R.H., Montes A., Childs M., Li J.R., Mabuchi H. Metabolic adjustments in normal and diabetic pregnancy. Clin Obstet Gynecol. 24:1981;21-49.
6. Stowers J.M., Sutherland H.W., Kerridge D. Long range implications for the mother. The Aberdeen experience. Diabetes. 34:(suppl 2):1985;106-110.
7. Dunaif A., Segal K.R., Futterweit W., Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes. 38:1989;1165-1174.
8. Lanzone A., Fulghesu A.M., Cucinelli F., Guido M., Pavone V., Caruso A., et al. Preconceptional and gestational evaluation of insulin secretion in patients with polycystic ovary syndrome. Hum Reprod. 11:1996;2382-2386.
9. Diamanti-Kandarakis E., Dunaif A. New perspectives in polycystic ovary syndrome. Trends Endocrinol Metab. 7:1996;267-271.
10. Yen S.S.C., Vela P., Rankin J. Inappropriate secretion of follicle-stimulating hormone and luteinizing hormone in polycystic ovarian disease. J Clin Endocrinol Metab. 30:1970;435-442.
11. Dunaif A., Givens J.R., Haseltine F., Merriam G.R. Polycystic ovary syndrome. 1992;Blackwell Scientific, Cambridge, Massachusetts.
12. Dahlgren E., Johansson S., Lindstedt G., Knutsson F., Oden A., Janson P.O., et al. Women with polycystic ovary syndrome wedge resected in 1956 to 1965 A long-term follow-up focusing on natural history and circulating hormones . Fertil Steril. 57:1992;505-513.
13. Chang R.J., Nakamura R.M., Judd H.L., Kaplan S.A. Insulin resistance in nonobese patients with polycystic ovarian disease. J Clin Endocrinol Metab. 57:1983;356-359.
14. Anttila L., Karjala K., Penttila R.A., Ruutiainen K., Ekblad U. Polycystic ovaries in women with gestational diabetes. Obstet Gynecol. 92:1998;13-16.
15. Polson D.W., Adams J., Wadsworth J., Franks S. Polycystic ovaries - a common finding in normal women. Lancet. i:1988;870-872.
16. Schachter M., Balen A.H., Patel A., Jacobs H.S. Hypogonadotropic patients with ultrasonographically detected polycystic ovaries Endocrine response to pulsatile gonadotropin-releasing hormone . Gynecol Endocrinol. 10:1996;327-335.
17. Dewailly D., Vantyghem-Haudiquet M.C., Sainsard C., Buvat J., Cappoen J.P., Ardaens K., et al. Clinical and biological phenotypes in late-onset 21-hydroxylase deficiency. J Clin Endocrinol Metab. 63:1986;418-423.
18. O'Meara N.M., Blackman J.D., Ehrmann D.A., Barnes R.B., Jaspan J.B., Rosenfield R.L., et al. Defects in beta-cell function in functional ovarian hyperandrogenism. J Clin Endocrinol Metab. 76:1993;1241-1247.
19. Hod M., Merlob P., Friedman S., Schoenfeld A., Ovadia J. Gestational diabetes mellitus. A survey of perinatal complications in the 1980s. Diabetes. 40:(suppl 2):1991;74-78.